Published in Ross Fiziol Zh Im I M Sechenova on November 01, 1998
Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats. J Mol Cell Cardiol (2010) 1.75
[Significance of cardiac cannabinoid receptors in regulation of cardiac rhythm, myocardial contractility, and electrophysiologic processes in heart]. Izv Akad Nauk Ser Biol (2007) 0.99
Endogenous cannabinoids improve myocardial resistance to arrhythmogenic effects of coronary occlusion and reperfusion: a possible mechanism. Bull Exp Biol Med (2002) 0.85
Cannabinoid receptor antagonists SR141716 and SR144528 exhibit properties of partial agonists in experiments on isolated perfused rat heart. Bull Exp Biol Med (2005) 0.85
Activation of type II cannabinoid receptors improves myocardial tolerance to arrhythmogenic effects of coronary occlusion and reperfusion. Bull Exp Biol Med (2001) 0.83
Activation of kappa-opioid receptor as a method for prevention of ischemic and reperfusion arrhythmias: role of protein kinase C and K(ATP) channels. Bull Exp Biol Med (2007) 0.82
[Anandamide and R-(+)-methanandamide prevent development of ischemic and reperfusion arrhythmia in rats by stimulation of CB2-receptors]. Eksp Klin Farmakol (2002) 0.82
[Neuroprotective effect of ischemic postconditioning and remote preconditioning. Prospective of clinical use]. Angiol Sosud Khir (2012) 0.80
[Cardioprotective and antiarrhythmic properties of Rhodiolae roseae preparations]. Eksp Klin Farmakol (2007) 0.80
[Cardioprotective effect of remote ischemic preconditioning]. Angiol Sosud Khir (2009) 0.80
[Reactive oxygen species are triggers and mediators of an increase in cardiac tolerance to impact of ischemia-reperfusion]. Ross Fiziol Zh Im I M Sechenova (2015) 0.79
Ligands for opioid and sigma-receptors improve cardiac electrical stability in rat models of post-infarction cardiosclerosis and stress. Life Sci (1999) 0.79
Activation of cannabinoid receptors decreases the area of ischemic myocardial necrosis. Bull Exp Biol Med (2002) 0.78
[The cardioprotective and antiadrenergic activity of an extract of Rhodiola rosea in stress]. Eksp Klin Farmakol (1995) 0.78
[Increase of the heart arrhythmogenic resistance and decrease of the myocardial necrosis zone during activation of cannabinoid receptors]. Ross Fiziol Zh Im I M Sechenova (2002) 0.78
Role of Intracellular Calcium and Cyclic Nucleotides in Realization of Cardioprotective Effects of δ(1)- and κ(1)-Opioid Receptor Agonists. Bull Exp Biol Med (2009) 0.78
Cardioprotective effect of kappa1-opioid receptor activation and role of cAMP in its realization. Bull Exp Biol Med (2007) 0.78
[Delta-opioid receptor agonists prevent the irreversible damage of cardiomyocytes in ischemized-reperfused isolated rat heart]. Eksp Klin Farmakol (2005) 0.77
Opioid receptors and heart resistance to arrhythmogenic factors. Bull Exp Biol Med (2004) 0.77
[Role of kappa1 opioid receptors and cAMP in regulation of cardiac tolerance to ischemia and reperfusion]. Izv Akad Nauk Ser Biol (2008) 0.77
[Do endogenous ligands of peripheral mu- and delta-opiate receptors mediate anti-arrhythmic and cardioprotective effects of Rhodiola rosea extract?]. Biull Eksp Biol Med (1997) 0.77
[Role of delta opioid receptors and their ligands in the development of adaptive heart protection against arrhythmogenesis]. Ross Fiziol Zh Im I M Sechenova (2001) 0.77
Effect of stress adaptation on cyclic nucleotide content in myocardial tissue during acute ischemia/reperfusion. Bull Exp Biol Med (2008) 0.77
[Problem of end-effector of ischemic postconditioning of the heart]. Ross Fiziol Zh Im I M Sechenova (2013) 0.77
[The role of sarcolemmal and mitochondrial K(ATP)-channels in realization of the cardioprotection and antiarrhythmic effect of different regimens of hypobaric adaptation]. Ross Fiziol Zh Im I M Sechenova (2009) 0.77
[Antiarrhythmic effect of the antiopioid peptide nociceptin and its effect on fast Na+-channels in cardiomyocytes]. Biull Eksp Biol Med (1998) 0.77
[Hypoxic preconditioning of stem cells as a new approach to increase the efficacy of cell therapy for myocardial infarction]. Vestn Ross Akad Med Nauk (2013) 0.77
Functional state of myocardial mitochondria in ischemia reperfusion of the heart in rats adapted to hypoxia. Bull Exp Biol Med (2014) 0.77
[Participation of K(ATP)-channels in cardioprotective effect of mu-opioid receptor agonists in acute ischemia and reperfusion of the isolated heart]. Eksp Klin Farmakol (2001) 0.77
[The participation of the mu-, delta- and kappa-opioid receptors in the realization of the anti-arrhythmia effect of Rhodiola rosea]. Eksp Klin Farmakol (1997) 0.77
[Effect of cold stress on the contractile activity, carbohydrate and energy metabolism in the isolated rat heart]. Patol Fiziol Eksp Ter (1997) 0.76
[Effect of a Rhodiolae rosea extract on the level of inducible HSP-70 in the myocardium under stress]. Biull Eksp Biol Med (1996) 0.76
[The anti-arrhythmia and pro-arrhythmia properties of sigma-receptor ligands]. Eksp Klin Farmakol (2000) 0.76
[Specificity of the anti-arrhythmic effect of kappa1-opioid receptor agonists]. Eksp Klin Farmakol (2001) 0.76
[Anti-arrhythmia effects of enkephalinase inhibitors]. Eksp Klin Farmakol (2001) 0.76
[Signaling mechanism of neuroprotective effect of ischemic preconditioning of brain]. Patol Fiziol Eksp Ter (2013) 0.76
Stimulation of mu and delta-Opiate Receptors and Tolerance of Isolated Heart to Oxidative Stress: the Role of NO-Synthase. Biochemistry (Mosc) (2001) 0.76
[Role of heat shock proteins, aldose reductase, Bcl-2 protein and microRNA in the mechanism of delayed preconditioning of heart]. Ross Fiziol Zh Im I M Sechenova (2010) 0.76
Cardiac contractility after transplantation of autologous mononuclear bone marrow cells in patients with myocardial infarction. Bull Exp Biol Med (2006) 0.76
Receptor specificity of the antiarrhythmic effect produced by opioid peptides Dalargin and DADLE during myocardial reperfusion. Bull Exp Biol Med (2002) 0.76
[Role of kappa-opioid receptors in the regulation of cardiac resistance to arrhythmogenic effects of ischemia and reperfusion]. Ross Fiziol Zh Im I M Sechenova (2006) 0.76
[Ischemic postconditioning of the heart. Receptor mechanisms and possibility of clinical use]. Kardiologiia (2010) 0.76
[Trigger mechanism of adaptive phenomenon of ischemic heart postconditioning]. Ross Fiziol Zh Im I M Sechenova (2012) 0.76
Cardioprotective Activity of Ganoderma lucidum Extract during Total Ischemia and Reperfusion of Isolated Heart. Bull Exp Biol Med (2015) 0.75
[Neuroprotective and cardioprotective effects of hypothermic preconditioning]. Patol Fiziol Eksp Ter (2012) 0.75
[Perspective of creation of drugs on basis of opioids increasing cardiac tolerance to pathogenic impact of ischemia reperfusion]. Eksp Klin Farmakol (2012) 0.75
[Effect of stimulation of mu-opiate receptors on contractility of the isolated heart in normal oxygenation and during ischemia-reperfusion]. Ross Fiziol Zh Im I M Sechenova (2001) 0.75
[Antiarrhythmic and cardioprotective effect of stimulation of delta1-opiate receptors in myocardial ischemia and reperfusion]. Patol Fiziol Eksp Ter (2004) 0.75
[The effect of stimulation of cardiac delta1-opioid receptors on the resistance of isolated heart to the action of ischemia and reperfusion]. Eksp Klin Farmakol (2006) 0.75
[SIGNALING MECHANISM OF CARDIOPROTECTIVE EFFECT OF REACTIVE OXYGEN SPECIES]. Ross Fiziol Zh Im I M Sechenova (2015) 0.75
[Intracellular mechanisms of opioidergic regulation of the myocardial function during normoxia and postischemic reperfusion]. Ross Fiziol Zh Im I M Sechenova (2009) 0.75
[The antiarrhythmic effect of (-)-U-50,488 in rats with acute ischemia and reperfusion of heart is mediated by kappa1-opioid receptor activation]. Eksp Klin Farmakol (2005) 0.75
[Role of kappa1 opioid receptors and cAMP in regulation of cardiac tolerance to ischemia and reperfusion]. Izv Akad Nauk Ser Biol (2008) 0.75
[Anti-arrhythmic effect of phytoadaptogens]. Eksp Klin Farmakol (2000) 0.75
[Interactions of peripheral mu-opioid receptors and K(ATP)-channels in regulation of cardiac electrical stability in ischemia, reperfusion, and postinfarction cardiosclerosis]. Ross Fiziol Zh Im I M Sechenova (2002) 0.75
K(ATP) channels mediate the antihypertrophic effects afforded by κ-opioid receptor stimulation in neonatal rat ventricular myocytes. Exp Ther Med (2012) 0.75
[Dependence of the pump function of the isolated rat heart on the functional activity of sigma receptors during reperfusion]. Ross Fiziol Zh Im I M Sechenova (1999) 0.75
[Significance of opioid receptors in regulation of cardiac tolerance in pathogenic impact of long-term ischemia-reperfusion in vivo]. Ross Fiziol Zh Im I M Sechenova (2009) 0.75
Participation of central kappa-opioid receptor in arrhythmogenesis. Life Sci (1997) 0.75
[Comparative study of the antiarrhythmic activity of mu- and delta-opioid receptor agonists during acute cardiac ischemia and reperfusion models in rats]. Eksp Klin Farmakol (2006) 0.75
[Delta-opioid receptor activation prevents appearance of irreversible damages of cardiomyocytes and exacerbates myocardial contractility dysfunction during ischemia and reperfusion]. Patol Fiziol Eksp Ter (2007) 0.75
[Blood-brain barrier permeability for the ligands of opioid receptors]. Eksp Klin Farmakol (2002) 0.75
Participation of central and peripheral kappa 1 and kappa 2 opioid receptors in arrhythmogenesis. Clin Exp Pharmacol Physiol (1999) 0.75
[Contribution of the endogenous opioid system to regulation of heart resistance to the arrhythmogenic effect of short-term ischemia and reperfusio]. Izv Akad Nauk Ser Biol (2005) 0.75
[The role of delta-1 opiate receptors in regulation of contractility in isolated rat heart during normal oxygenation and ischemia-reperfusion]. Izv Akad Nauk Ser Biol (2004) 0.75
[Cardioprotective effects of adaptogens of plant origin]. Biull Eksp Biol Med (1993) 0.75
[The opiate system in the regulation of central hemodynamics]. Patol Fiziol Eksp Ter (2003) 0.75
[Modulating effect of mu-opioid receptor ligands on adrenergic mechanism of stressor heart damage pathogenesis]. Biull Eksp Biol Med (1998) 0.75
[Participation of the prostacyclin-thromboxane system in the mechanisms of prevention of arrhythmia caused by occlusion of the coronary artery in adapted rats]. Biull Eksp Biol Med (1991) 0.75
[Participation of endogenous mu- and delta-opiate receptor agonists in mechanisms of the anti-arrhythmia effect of adaptation]. Biull Eksp Biol Med (1996) 0.75
Possible mechanism underlying the antiarrhythmic effect of peptides nociceptin and DALDA on the heart. Bull Exp Biol Med (2003) 0.75
[Participation of central opiate receptors in the pathogenesis of adrenal arrhythmias]. Biull Eksp Biol Med (1994) 0.75
[The limitation of the intensity of the stress reaction under open-field test conditions through the adaptation of rats to cold and physical loading]. Zh Vyssh Nerv Deiat Im I P Pavlova (1994) 0.75
[Modulation of the antiarrhythmic effect by endogenous opioids during adaptation to hypoxia in rats]. Ross Fiziol Zh Im I M Sechenova (1998) 0.75
[The use of central administration of the delta1- and delta2-opiate receptor agonists for prevention of the experimental adrenal arrhythmias]. Biull Eksp Biol Med (1997) 0.75
[The use of opiate receptor ligands for correction of heart electrical instability]. Biull Eksp Biol Med (1998) 0.75
[The anti-arrhythmic effect of the selective sigma-receptor antagonist DuP 734 [1-(cyclopropylmethyl)-4-(2'-(4''-fluorophenyl)-2'-oxoethyl)piper idine HBr]]. Eksp Klin Farmakol (1997) 0.75
[The anti-arrhythmia action of an extract of Rhodiola rosea and of n-tyrosol in models of experimental arrhythmias]. Eksp Klin Farmakol (1998) 0.75
Effect of in vivo and in vitro stimulation of delta1-opioid receptors on myocardial resistance to arrhythmogenic action of ischemia and reperfusion. Bull Exp Biol Med (2002) 0.75
[Status of the stress-realizing and stress-limiting systems in acute myocardial infarction]. Patol Fiziol Eksp Ter (1995) 0.75
[Effect of Rodiola rosacea on the resistance of isolated heart from stressed-out rats to ischemic and reperfusion injury]. Biull Eksp Biol Med (1997) 0.75
[Changes in cardiac resistance to arrhythmogenic effects during ATP-dependent K+ channel activation]. Ross Fiziol Zh Im I M Sechenova (2003) 0.75
[Do endogenous opioid peptides participate in the realization of the cardioprotective effect of adaptation?]. Patol Fiziol Eksp Ter (1997) 0.75
[Contribution of the opioid system to realization of inotropic effects of Rhodiola rosea extracts in ischemic and reperfusion heart damage in vitro]. Eksp Klin Farmakol (1997) 0.75
[The opiatergic link between the antiarrhythmic effect of adaptation and hypoxia in the model of ischemia and reperfusion in vivo]. Patol Fiziol Eksp Ter (2003) 0.75
[Endogenous opioid system and resistance of the heart against arrhythmogenic influences]. Kardiologiia (2002) 0.75
[Diurnal fluctuations of plasma renin activity and aldosterone level in patients with arterial hypertension]. Kardiologiia (1990) 0.75
[Opiatergic mechanisms of cardioprotective and anti-arrhythmic effects of adaptation]. Biull Eksp Biol Med (1999) 0.75
[Prevention of arrhythmia by periodic hypoxia is mediated by activation of mu- and delta-opioid receptors]. Biull Eksp Biol Med (1998) 0.75
[Peripheral mu-opiate receptors and regulation of cardiac resistance to arrhythmogenic effects]. Biull Eksp Biol Med (1998) 0.75
[The role of peripheral and central mu-opiate receptors in the modulation of adrenergic cardiac lesions during stress]. Ross Fiziol Zh Im I M Sechenova (1998) 0.75
[Central K1-opiate receptors and mechanisms of arrhythmogenesis]. Biull Eksp Biol Med (1997) 0.75
[Opioid peptides in the dynamics of "physiological" and "pathological" stress]. Patol Fiziol Eksp Ter (1991) 0.75
[An experimental study of the pharmacological activity of opiate receptor ligands on models of adrenaline-induced arrhythmias]. Eksp Klin Farmakol (1995) 0.75
[Significance of delta1-opioid receptors for regulation of the isolated heart resistance to ischemia-reperfusion]. Kardiologiia (2003) 0.75
[The role of the mu and delta types of the peripheral opiate receptors in regulating cardiac resistance to arrhythmogenic actions]. Ross Fiziol Zh Im I M Sechenova (1997) 0.75
[Mechanism of the anti-arrhythmic effect of Rhodiola rosea extract]. Biull Eksp Biol Med (1998) 0.75
[Adrenergic regulation of the level of enkephalins in the myocardium]. Vopr Med Khim (1989) 0.75